dr anne reihman: antiil-5 therapies can be life-changing for patients with eosinophilic asthma
Published 3 years ago • 1.5K plays • Length 2:35Download video MP4
Download video MP3
Similar videos
-
1:52
dr anne reihman talks unraveling the mystery of patients who do not respond to anti-il-5 treatment
-
4:16
linda rogers, ats 2018 – treatment of severe eosinophilic asthma with il-5 antagonists
-
0:55
what is severe asthma?
-
22:00
novel insights in eosinophilic asthma
-
4:28
mepalizumab in eosinophilic asthma
-
1:00:59
clinical profiles in severe eosinophilic asthma
-
4:49
severely, asthma! - episode 1: the diagnosis of severe asthma, peter's story
-
5:23
asthma phenotypes
-
7:51
what is eosinophilic asthma?
-
0:29
large asd with lv dysfunction
-
1:00
air supply: targeting eosinophils in severe asthma
-
1:50
newly approved asthma treatment could be a game changer – 5 news
-
1:34
what is it like living with severe asthma?
-
27:38
biology and therapy of eosinophilic mpns
-
1:50
what you need to know about eosinophilic asthma | presented by astrazeneca
-
1:06:10
05/26/2020 neuro-immune interactions in eosinophilic asthma
-
5:13
marios panagiotou, ers 2018 – daily physical activity in patients with severe eosinophilic asthma
-
9:20
mepolizumab and omalizumab - evidence for use in severe asthma -- bavls
-
15:25
module 5 treatment mepolizumab reslizumab benralizumab
-
5:09
reslizumab in adult, severe eosinophilic asthma
-
5:41
il-5–inhibiting agents mepolizumab, benralizumab, and reslizumab
-
1:04
dr. jamie rutland: eosinophilic asthma